Business ❯ Healthcare ❯ Pharmaceuticals

Oncology

Clinical Trials Drug Development Pediatric Cancer Keytruda Cancer Immunotherapy Precision Medicine Product Development Antibody-Drug Conjugates Cisplatin-Induced Ototoxicity Myelofibrosis Antibody Drug Conjugates Research and Development Darzalex Cancer Medicines Targeted Therapies Cancer Drugs Chronic Myeloid Leukaemia Guardant Health Collaboration Partnerships Acute Leukaemia Speciality Care Drug Sales Growth Lung Cancer Drug Delivery Devices CAR-T Therapies Sales Performance Cancer Therapy Data Collaboration Johnson & Johnson Gastrointestinal Cancers

4 ARTICLES

3w ago

Multiple Firms Vie to Lead Erasca Securities Suits After April Disclosures

A looming court deadline will decide who controls discovery into patent claims, preclinical comparisons and safety reports that investors say were concealed.

6 ARTICLES

last mo.

Multiple Law Firms Seek Erasca Investors Ahead of August Lead‑Plaintiff Deadline

7 ARTICLES

last mo.

Erasca Faces Securities Suit Over ERAS-0015 After Patent Claim and Trial Death Disclosures

7 ARTICLES

3mo ago

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

3 ARTICLES

4mo ago

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

8 ARTICLES

4mo ago

C-Further Launches First Pediatric Cancer Programs, Taps MiNK for PRAME iNKT Therapy

4 ARTICLES

7mo ago

Merck Lifts Mid-2030s Revenue Goal to $70 Billion From Emerging Businesses

10 ARTICLES

7mo ago

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

6 ARTICLES

8mo ago

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

8 ARTICLES

10mo ago

J&J to Spin Off $9 Billion Orthopedics Unit as DePuy Synthes Within Two Years

5 ARTICLES

11mo ago

Oncology

Multiple Firms Vie to Lead Erasca Securities Suits After April Disclosures

Multiple Law Firms Seek Erasca Investors Ahead of August Lead‑Plaintiff Deadline

Erasca Faces Securities Suit Over ERAS-0015 After Patent Claim and Trial Death Disclosures

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Gilead Expands Tempus Partnership for Enterprise Access to AI Oncology Platform

Gilead to Acquire Tubulis for Up to $5 Billion to Boost Cancer ADC Pipeline

Karyopharm Raises $30 Million in RA Capital Private Placement

C-Further Launches First Pediatric Cancer Programs, Taps MiNK for PRAME iNKT Therapy

Merck Lifts Mid-2030s Revenue Goal to $70 Billion From Emerging Businesses

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

J&J to Spin Off $9 Billion Orthopedics Unit as DePuy Synthes Within Two Years

Pfizer Lifts 2025 EPS Outlook, Targets $7.7 Billion in Savings as Dividend Draws Interest

Never miss stories about

Oncology